In contrast, Maoa expression exhibited a slight downregulation in response to both treatments (EVs: −0.94 ± 0.15-fold; CFS: −0.34 ± 0.10-fold), though these changes did not reach statistical significance (P = 0.096). This evidence concerns the gene MAOA and myalgic encephalomeyelitis/chronic fatigue syndrome.